Healthy aging
Geriatric care assessment: a coordinated plan beyond a screening score
On this page
Comprehensive geriatric assessment, or CGA, is a coordinated process that assesses an older person’s health, function and wider circumstances, then develops, implements and reviews a care plan. It addresses what matters to the person as well as medical findings.[1]
Distinguish screening, assessment and coordinated management
| Type or component | Purpose | Boundary |
|---|---|---|
| Brief frailty screening | Identify possible need for fuller assessment | A score does not implement a care plan[1] |
| Medical and medicine review | Consider conditions, symptoms and treatment burden | One condition is not the whole assessment[1] |
| Function and social context | Consider daily activities, support and environment | Needs are individual[1] |
| Brief cognitive assessment | Identify possible cognitive difficulty | A positive result needs further evaluation[3] |
| Hospital CGA | Coordinated multidisciplinary care during admission | Different from a one-off checklist[5] |
| Community integrated care | Identify declines and support needs; personalize care | Local services shape implementation[2] |
| Discharge coordination | Connect hospital plans with community support | The handover needs named responsibility[4] |
Assessment should lead to action and review
The British Geriatrics Society describes CGA as assessment followed by a personalized plan, interventions and reassessment. Physical, psychological, functional, social and medicine-related issues can interact. Different health and social care professionals contribute, with coordination by someone the person trusts. A brief score can help identify who needs this process, but cannot replace the discussion, agreed actions or follow-up. Ask who coordinates the plan and how progress will be reviewed.[1]
Community pathways need a workable local plan
WHO’s second-edition ICOPE handbook supports primary and community care workers in identifying declines in intrinsic capacity and social care or support needs, then developing a personalized plan. It calls for adaptation to the local context. This is an implementation framework, not a single diagnostic score or proof that every service delivers the same result. Ask which needs can be addressed locally and how specialist advice, rehabilitation and social support will be connected.[2]
A memory test is one part of assessment
The National Institute on Aging advises further evaluation after a positive brief cognitive assessment. Memory difficulties can have different causes, including medicine effects and other medical conditions. A fuller history, function assessment and information from someone the person knows can help clarify the problem. One low score does not by itself diagnose dementia, describe every care need or decide who makes treatment decisions. Ask what the result means and what assessment should follow.[3]
A care plan must survive the move between services
NICE recommends involving the person in discharge planning, sharing information and arranging health and social care support. It discusses a discharge coordinator and early supported discharge with a home-care and rehabilitation package for older people with identified social care needs. Before leaving hospital, ask who receives the plan, which medicines have changed, what help is arranged and whom to contact if it does not arrive. These are care-transition recommendations, not evidence that discharge paperwork alone constitutes CGA.[4]
Evidence & uncertainty
Hospital CGA has evidence for increasing the chance of being alive at home after admission. That combined outcome is not proof of lower mortality alone. Community care, cancer-treatment assessment and brief screening have different populations, purposes and evidence.[5]
Selected-source overview · Independent review pendingPublished questions
Is a frailty score the same as comprehensive geriatric assessment?
Selected-source overview · Independent review pending. Read the evidence context.
No. BGS describes assessment, a personalized plan, interventions and review. A screening score can identify possible need, but does not deliver that coordinated process.[1]
Evidence behind this answer
- CGA in Primary Care Settings: Introduction
professional association practice guidance · 2019
Selected original substantive page passages inspected · Definition, assessment-plan-intervention-review cycle, coordination and screening versus fuller assessment
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a low memory-test score diagnose dementia?
Selected-source overview · Independent review pending. Read the evidence context.
No. NIA advises further evaluation after a positive brief assessment. Different medical causes and medicine effects can contribute, and the fuller clinical picture matters.[3]
Evidence behind this answer
- Assessing Cognitive Impairment in Older Patients
agency clinical assessment explanation · 2023
Selected original indexed substantive agency passages and displayed review date inspected; direct page blocked · Brief positive assessment requires evaluation; alternative medical causes, function/history and informant role
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Did hospital CGA prove that it reduces deaths?
Selected-source overview · Independent review pending. Read the evidence context.
The Cochrane review found little or no mortality difference. It improved the combined outcome of being alive at home and reduced nursing-home admission; those outcomes are different.[5]
Evidence behind this answer
- Comprehensive geriatric assessment for older adults admitted to hospital
systematic review of randomized trials · 2017
Original review plain-language summary, abstract and selected methods/results inspected · 29 trials/13766 participants; alive at home, nursing-home admission, mortality/dependence and uncertainty; search October 2016
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are the hospital results guaranteed for people living at home?
Selected-source overview · Independent review pending. Read the evidence context.
No. The community review evaluated a different population and setting. It found little or no nursing-home admission benefit and only low-certainty evidence of fewer hospital admissions.[6]
Evidence behind this answer
- Comprehensive Geriatric Assessment for older people in the community at risk of poor health outcomes
systematic review of randomized trials · 2022
Original review plain-language summary, abstract and selected methods/results inspected · 21 studies/7893 participants, community frailty population, mortality/nursing-home/hospital outcomes and quality limits
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does the cancer trial apply to all older people?
Selected-source overview · Independent review pending. Read the evidence context.
No. GAP70+ studied people aged seventy or older with incurable cancer, geriatric impairments and a new treatment regimen. Its toxicity result is specific to that context.[7]
Evidence behind this answer
- Evaluation of geriatric assessment and management on the toxic effects of cancer treatment: GAP70+
cluster randomized controlled trial · 2021
Original investigators’ institutional methods/results abstract record inspected; full trial report not independently appraised · 40 practices/718 patients aged70+, incurable cancer, impairment, summaries plus management; grade3–5 toxicity51% vs71%
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Did GERICO establish longer survival?
Selected-source overview · Independent review pending. Read the evidence context.
No survival difference was demonstrated, and the trial was too small for a firm survival conclusion. Its main finding concerned chemotherapy completion, especially in the adjuvant subgroup.[8]
Evidence behind this answer
- The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial
randomized controlled trial · 2021
Selected original full-report methods/results, subgroup and limitation passages inspected · 142 analyzed, G8-selected vulnerability, intervention components, completion45% vs28%, subgroup and survival limitations
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What should I ask before leaving hospital?
Selected-source overview · Independent review pending. Read the evidence context.
Ask who coordinates the handover, which medicines changed, what home support or rehabilitation is arranged, and whom to contact if the plan fails. NICE recommends involving the person in discharge planning.[4]
Evidence behind this answer
- Transition between inpatient hospital settings and community or care home settings for adults with social care needs: NG27 recommendations
agency clinical and social care guideline · 2015
Selected original indexed recommendation passages and official guidance publication listing inspected; direct page unavailable · Person involvement, discharge coordination/information and older-person home-care/rehabilitation packages
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Should every community use an identical assessment pathway?
Selected-source overview · Independent review pending. Read the evidence context.
No. WHO’s ICOPE handbook calls for local adaptation and a personalized plan. Available services, support needs and individual priorities shape useful follow-up.[2]
Evidence behind this answer
- Integrated care for older people: guidance for person-centred assessment and pathways in primary care, second edition
agency care implementation handbook · 2025
Original publication-page substantive overview inspected; linked full handbook retrieval failed · Official overview: intrinsic-capacity declines, social/support needs, personalized plan and local adaptation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Hospital trials support coordinated care with specific outcome limits
The 2017 Cochrane review included 29 trials and 13,766 participants, mostly in high-income countries. Compared with routine inpatient care, CGA increased the chance of being alive at home at three to twelve months and reduced nursing-home admission. It made little or no difference to mortality alone or dependence in everyday activities. Cognitive outcomes, hospital-stay duration and costs were less certain or variable. The intervention involved organized care, often a specialist ward or team, rather than merely administering a screening questionnaire. The evidence search ended in October 2016, so this is a dated synthesis.[5]
Community results should not be borrowed from hospital trials
A separate 2022 Cochrane review included 21 studies and 7,893 community-dwelling frail older people. CGA probably made little or no difference to mortality and made little or no difference to nursing-home admission. Low-certainty evidence suggested fewer unplanned hospital admissions. Evidence was insufficient for confident conclusions about some other outcomes. Teams, populations and usual care varied, and searches ended in April 2020. The findings support a measured discussion of possible benefits, without promising that a home assessment reproduces the inpatient result.[6]
Cancer-treatment assessment can change a defined treatment outcome
The GAP70+ trial randomized forty US community oncology practices and included 718 people aged seventy or older with incurable cancer and at least one geriatric-domain impairment. Oncologists receiving assessment summaries and management recommendations had patients with fewer grade three-to-five toxic effects over three months: 51% versus 71% with usual care. The result concerns assessment-guided management during a new cancer-treatment regimen. It does not establish a general mortality benefit, prove that age alone should exclude treatment or show that an assessment score without management has the same effect.[7]
A smaller cancer trial measured treatment completion
The GERICO trial studied 142 vulnerable patients aged seventy or older receiving chemotherapy for colorectal cancer. Interventions included medicine review, nutritional support and physiotherapy. Planned chemotherapy without subsequent dose reductions or delays was completed by 45% in the intervention group versus 28% with usual care. Its primary completion endpoint excluded oxaliplatin modifications. Benefit was clearest in the adjuvant-treatment subgroup; the palliative subgroup did not show a significant difference. Survival outcomes did not show a difference, and the trial was too small to establish a survival benefit. Its findings are specific to these patients and care arrangements.[8]
Completing an assessment is different from delivering the proposed care
The community review evaluated varied care packages. Its uncertain and outcome-specific results leave questions about which components, follow-up arrangements and populations benefit most. A local service should describe what happens after findings are identified and how recommendations become accessible care, rather than implying that detection alone ensures improvement.[6]
Access and priorities influence what a plan can achieve
WHO presents ICOPE as pathways to adapt locally. A plan must account for available care, support needs and the person’s priorities. Ask which action is most important now, who will carry it out and what to do if services are delayed. An ideal plan on paper is not a guaranteed clinical outcome.[2]
References
- CGA in Primary Care Settings: Introduction
Professional association practice guidance
British Geriatrics Society · Content/publication date: 2019
Accessed: 2026-10-14 UTC · Selected original substantive page passages inspected
Cited sections: Definition, assessment-plan-intervention-review cycle, coordination and screening versus fuller assessmentDated process guidance. Its broad mortality-benefit wording is not adopted; hospital outcome claims use the more specific Cochrane trial synthesis.
- Integrated care for older people: guidance for person-centred assessment and pathways in primary care, second edition
Agency care implementation handbook
World Health Organization · Content/publication date: 2025
Accessed: 2026-10-14 UTC · Original publication-page substantive overview inspected; linked full handbook retrieval failed
Cited sections: Official overview: intrinsic-capacity declines, social/support needs, personalized plan and local adaptationPage issued September 2025; book was also circulated with 2024 copyright, so page date is not represented as a wholly new 2025 trial or recommendation. Detailed handbook pathways not independently appraised.
- Assessing Cognitive Impairment in Older Patients
Agency clinical assessment explanation
National Institute on Aging · Content/publication date: 2023
Accessed: 2026-10-14 UTC · Selected original indexed substantive agency passages and displayed review date inspected; direct page blocked
Cited sections: Brief positive assessment requires evaluation; alternative medical causes, function/history and informant roleDoes not establish universal asymptomatic cognitive screening benefit, a diagnosis from one score or decision-making incapacity.
- Transition between inpatient hospital settings and community or care home settings for adults with social care needs: NG27 recommendations
Agency clinical and social care guideline
National Institute for Health and Care Excellence · Content/publication date: 2015
Accessed: 2026-10-14 UTC · Selected original indexed recommendation passages and official guidance publication listing inspected; direct page unavailable
Cited sections: Person involvement, discharge coordination/information and older-person home-care/rehabilitation packagesDated England-focused transition guidance; not identical to CGA trial intervention or a worldwide social-care entitlement.
- Comprehensive geriatric assessment for older adults admitted to hospital
Systematic review of randomized trials
Ellis and colleagues; Cochrane · Content/publication date: 2017
Accessed: 2026-10-14 UTC · Original review plain-language summary, abstract and selected methods/results inspected
Cited sections: 29 trials/13766 participants; alive at home, nursing-home admission, mortality/dependence and uncertainty; search October 2016Source GRADE ratings reported separately from Atlas formal grading, which remains incomplete. Ward-versus-team subgroup analysis underpowered; no setting-independent guarantee.
- Comprehensive Geriatric Assessment for older people in the community at risk of poor health outcomes
Systematic review of randomized trials
Briggs and colleagues; Cochrane · Content/publication date: 2022
Accessed: 2026-10-14 UTC · Original review plain-language summary, abstract and selected methods/results inspected
Cited sections: 21 studies/7893 participants, community frailty population, mortality/nursing-home/hospital outcomes and quality limitsSearches through April 2020. Does not import inpatient benefits; low-certainty hospital-admission evidence kept distinct from nursing-home results.
- Evaluation of geriatric assessment and management on the toxic effects of cancer treatment: GAP70+
Cluster randomized controlled trial
Mohile and colleagues; UT MD Anderson Cancer Center research repository · Content/publication date: 2021
Accessed: 2026-10-14 UTC · Original investigators’ institutional methods/results abstract record inspected; full trial report not independently appraised
Cited sections: 40 practices/718 patients aged70+, incurable cancer, impairment, summaries plus management; grade3–5 toxicity51% vs71%Same paper as PMID34741815, not an independent replication. Date is verified journal issue; online publication earlier in November. No general-population mortality claim.
- The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial
Randomized controlled trial
Lund and colleagues · Content/publication date: 2021
Accessed: 2026-10-14 UTC · Selected original full-report methods/results, subgroup and limitation passages inspected
Cited sections: 142 analyzed, G8-selected vulnerability, intervention components, completion45% vs28%, subgroup and survival limitationsOnline April2021; June2021 issue. 153 initially enrolled and142 analyzed; text says studied142 rather than claiming all142 were the original randomized population. Single-center, no survival-effect claim.
Scope & review
- Population
- Older adults with complex needs or frailty in hospital/community; selected older cancer populations explicitly distinguished
- Exposure or intervention
- Multidimensional assessment linked to management, follow-up and care transitions
- Comparison
- Hospital/community CGA versus usual care; cancer assessment-guided management versus usual care; brief cognitive assessment versus diagnostic evaluation
- Outcomes
- Alive at home, nursing-home/hospital admissions, mortality, treatment toxicity/completion and understandable care coordination
- Timeframe
- Assessment and handover through 3-month oncology outcomes and 3–12-month care outcomes
- Jurisdiction
- UK BGS/NICE process guidance, global WHO implementation framework, international reviews, US GAP70+ and Danish GERICO; service access and social-care arrangements vary
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-14 UTC: Added a bounded life-course care guide; qualified clinical, lived-experience and methods review remains pending.
What this article still leaves open
- Which components and follow-up arrangements improve outcomes in a particular community?
- How can assessment recommendations become timely accessible care?
- Which outcomes matter most to an individual older person?
- How do cancer-specific findings transfer to other illnesses, settings and levels of frailty?
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.